Use of PLG in open subacromial decompression lowers pain and improves function .
This report has been verified
by one or more authors of the
original publication.
Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study
Eur Surg Res. 2008;40(2):203-10. Epub17998780 2007 Nov 1240 patients underwent open subacromial decompression (OSD) surgery to treat impingement syndrome. During wound closure patients were randomized to either receive an injection of platelet-leukocyte gel (PLG) or not, so as to determine the impact of the PLG on recovery. Following 6 weeks of evaluation the results displayed that the healing process was significantly faster in patients who received an injection of PLG, which allowed for an earlier return to daily activities. In addition, these patients consumed less pain medication than patients in the control group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
